MOGAM

Welcome to the Brand page for “MOGAM”, which is offered here for Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, japanese encephalitis, hepatitis, hiv, hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, guillain-barre syndrome, kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatment of hepatitis b and influenza;wholesale distributorships and retail stores featuring pharmaceutical products; export and import agencies in the field of pharmaceutical products; financial intermediary services, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; operation of a business for others, wholesale distributorships and retail stores featuring pharmaceutical products; procurement, purchasing pharmaceutical products for other businesses;research and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies;.

Its status is currently believed to be active. Its class is unavailable. “MOGAM” is believed to be currently owned by “GREEN CROSS HOLDINGS CORPORATION”.